Serveur d'exploration sur la glutarédoxine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.

Identifieur interne : 000405 ( Main/Exploration ); précédent : 000404; suivant : 000406

The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.

Auteurs : Rie Ishikawa [Japon] ; Yosuke Amano [Japon] ; Masanori Kawakami [Japon] ; Mitsuhiro Sunohara [Japon] ; Kousuke Watanabe [Japon] ; Hidenori Kage [Japon] ; Nobuya Ohishi [Japon] ; Yutaka Yatomi [Japon] ; Jun Nakajima [Japon] ; Masashi Fukayama [Japon] ; Takahide Nagase [Japon] ; Daiya Takai [Japon]

Source :

RBID : pubmed:26685324

Descripteurs français

English descriptors

Abstract

Stage IA non-small-cell lung cancer cases have been recognized as having a low risk of relapse; however, occasionally, relapse may occur. To predict clinical outcome in Stage IA non-small-cell lung cancer patients, we searched for chimeric transcripts that can be used as biomarkers and identified a novel chimeric transcript, RUNX1-GLRX5, comprising RUNX1, a transcription factor, and GLRX5. This chimera was detected in approximately half of the investigated Stage IA non-small-cell lung cancer patients (44/104 cases, 42.3%). Although there was no significant difference in the overall survival rate between RUNX1-GLRX5-positive and -negative cases (P = 0.088), a significantly lower relapse rate was observed in the RUNX1-GLRX5-positive cases (P = 0.039), indicating that this chimera can be used as a biomarker for good prognosis in Stage IA patients. Detection of the RUNX1-GLRX5 chimeric transcript may therefore be useful for the determination of a postoperative treatment plan for Stage IA non-small-cell lung cancer patients.

DOI: 10.1093/jjco/hyv187
PubMed: 26685324
PubMed Central: PMC4731000


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.</title>
<author>
<name sortKey="Ishikawa, Rie" sort="Ishikawa, Rie" uniqKey="Ishikawa R" first="Rie" last="Ishikawa">Rie Ishikawa</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Amano, Yosuke" sort="Amano, Yosuke" uniqKey="Amano Y" first="Yosuke" last="Amano">Yosuke Amano</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Kawakami, Masanori" sort="Kawakami, Masanori" uniqKey="Kawakami M" first="Masanori" last="Kawakami">Masanori Kawakami</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Sunohara, Mitsuhiro" sort="Sunohara, Mitsuhiro" uniqKey="Sunohara M" first="Mitsuhiro" last="Sunohara">Mitsuhiro Sunohara</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Watanabe, Kousuke" sort="Watanabe, Kousuke" uniqKey="Watanabe K" first="Kousuke" last="Watanabe">Kousuke Watanabe</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Kage, Hidenori" sort="Kage, Hidenori" uniqKey="Kage H" first="Hidenori" last="Kage">Hidenori Kage</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Ohishi, Nobuya" sort="Ohishi, Nobuya" uniqKey="Ohishi N" first="Nobuya" last="Ohishi">Nobuya Ohishi</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Yatomi, Yutaka" sort="Yatomi, Yutaka" uniqKey="Yatomi Y" first="Yutaka" last="Yatomi">Yutaka Yatomi</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Clinical Laboratory, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Nakajima, Jun" sort="Nakajima, Jun" uniqKey="Nakajima J" first="Jun" last="Nakajima">Jun Nakajima</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Cardiothoracic Surgery, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Cardiothoracic Surgery, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Fukayama, Masashi" sort="Fukayama, Masashi" uniqKey="Fukayama M" first="Masashi" last="Fukayama">Masashi Fukayama</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Pathology, The University of Tokyo Hospital, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pathology, The University of Tokyo Hospital, Tokyo</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nagase, Takahide" sort="Nagase, Takahide" uniqKey="Nagase T" first="Takahide" last="Nagase">Takahide Nagase</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Takai, Daiya" sort="Takai, Daiya" uniqKey="Takai D" first="Daiya" last="Takai">Daiya Takai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo dtakai-ind@umin.ac.jp.</nlm:affiliation>
<country wicri:rule="url">Japon</country>
<wicri:regionArea>Department of Clinical Laboratory, The University of Tokyo Hospital</wicri:regionArea>
<wicri:noRegion>The University of Tokyo Hospital</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26685324</idno>
<idno type="pmid">26685324</idno>
<idno type="doi">10.1093/jjco/hyv187</idno>
<idno type="pmc">PMC4731000</idno>
<idno type="wicri:Area/Main/Corpus">000476</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000476</idno>
<idno type="wicri:Area/Main/Curation">000476</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000476</idno>
<idno type="wicri:Area/Main/Exploration">000476</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.</title>
<author>
<name sortKey="Ishikawa, Rie" sort="Ishikawa, Rie" uniqKey="Ishikawa R" first="Rie" last="Ishikawa">Rie Ishikawa</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Amano, Yosuke" sort="Amano, Yosuke" uniqKey="Amano Y" first="Yosuke" last="Amano">Yosuke Amano</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Kawakami, Masanori" sort="Kawakami, Masanori" uniqKey="Kawakami M" first="Masanori" last="Kawakami">Masanori Kawakami</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Sunohara, Mitsuhiro" sort="Sunohara, Mitsuhiro" uniqKey="Sunohara M" first="Mitsuhiro" last="Sunohara">Mitsuhiro Sunohara</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Watanabe, Kousuke" sort="Watanabe, Kousuke" uniqKey="Watanabe K" first="Kousuke" last="Watanabe">Kousuke Watanabe</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Kage, Hidenori" sort="Kage, Hidenori" uniqKey="Kage H" first="Hidenori" last="Kage">Hidenori Kage</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Ohishi, Nobuya" sort="Ohishi, Nobuya" uniqKey="Ohishi N" first="Nobuya" last="Ohishi">Nobuya Ohishi</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Yatomi, Yutaka" sort="Yatomi, Yutaka" uniqKey="Yatomi Y" first="Yutaka" last="Yatomi">Yutaka Yatomi</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Clinical Laboratory, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Nakajima, Jun" sort="Nakajima, Jun" uniqKey="Nakajima J" first="Jun" last="Nakajima">Jun Nakajima</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Cardiothoracic Surgery, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Cardiothoracic Surgery, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Fukayama, Masashi" sort="Fukayama, Masashi" uniqKey="Fukayama M" first="Masashi" last="Fukayama">Masashi Fukayama</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Pathology, The University of Tokyo Hospital, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pathology, The University of Tokyo Hospital, Tokyo</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nagase, Takahide" sort="Nagase, Takahide" uniqKey="Nagase T" first="Takahide" last="Nagase">Takahide Nagase</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</nlm:affiliation>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<wicri:orgArea>Department of Respiratory Medicine, The University of Tokyo Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Takai, Daiya" sort="Takai, Daiya" uniqKey="Takai D" first="Daiya" last="Takai">Daiya Takai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo dtakai-ind@umin.ac.jp.</nlm:affiliation>
<country wicri:rule="url">Japon</country>
<wicri:regionArea>Department of Clinical Laboratory, The University of Tokyo Hospital</wicri:regionArea>
<wicri:noRegion>The University of Tokyo Hospital</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Japanese journal of clinical oncology</title>
<idno type="eISSN">1465-3621</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged (MeSH)</term>
<term>Biomarkers, Tumor (analysis)</term>
<term>Carcinoma, Non-Small-Cell Lung (chemistry)</term>
<term>Carcinoma, Non-Small-Cell Lung (pathology)</term>
<term>Chimera (MeSH)</term>
<term>Core Binding Factor Alpha 2 Subunit (analysis)</term>
<term>Female (MeSH)</term>
<term>Glutaredoxins (analysis)</term>
<term>Humans (MeSH)</term>
<term>Lung Neoplasms (chemistry)</term>
<term>Lung Neoplasms (pathology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Neoplasm Recurrence, Local (MeSH)</term>
<term>Neoplasm Staging (MeSH)</term>
<term>Postoperative Period (MeSH)</term>
<term>Predictive Value of Tests (MeSH)</term>
<term>Prognosis (MeSH)</term>
<term>Survival Analysis (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen (MeSH)</term>
<term>Analyse de survie (MeSH)</term>
<term>Carcinome pulmonaire non à petites cellules (anatomopathologie)</term>
<term>Carcinome pulmonaire non à petites cellules (composition chimique)</term>
<term>Chimère (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Glutarédoxines (analyse)</term>
<term>Humains (MeSH)</term>
<term>Marqueurs biologiques tumoraux (analyse)</term>
<term>Mâle (MeSH)</term>
<term>Pronostic (MeSH)</term>
<term>Période postopératoire (MeSH)</term>
<term>Récidive tumorale locale (MeSH)</term>
<term>Sous-unité alpha 2 du facteur CBF (analyse)</term>
<term>Stadification tumorale (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Tumeurs du poumon (anatomopathologie)</term>
<term>Tumeurs du poumon (composition chimique)</term>
<term>Valeur prédictive des tests (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Biomarkers, Tumor</term>
<term>Core Binding Factor Alpha 2 Subunit</term>
<term>Glutaredoxins</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Glutarédoxines</term>
<term>Marqueurs biologiques tumoraux</term>
<term>Sous-unité alpha 2 du facteur CBF</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Carcinome pulmonaire non à petites cellules</term>
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Carcinome pulmonaire non à petites cellules</term>
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Chimera</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Neoplasm Staging</term>
<term>Postoperative Period</term>
<term>Predictive Value of Tests</term>
<term>Prognosis</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Chimère</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pronostic</term>
<term>Période postopératoire</term>
<term>Récidive tumorale locale</term>
<term>Stadification tumorale</term>
<term>Sujet âgé</term>
<term>Valeur prédictive des tests</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Stage IA non-small-cell lung cancer cases have been recognized as having a low risk of relapse; however, occasionally, relapse may occur. To predict clinical outcome in Stage IA non-small-cell lung cancer patients, we searched for chimeric transcripts that can be used as biomarkers and identified a novel chimeric transcript, RUNX1-GLRX5, comprising RUNX1, a transcription factor, and GLRX5. This chimera was detected in approximately half of the investigated Stage IA non-small-cell lung cancer patients (44/104 cases, 42.3%). Although there was no significant difference in the overall survival rate between RUNX1-GLRX5-positive and -negative cases (P = 0.088), a significantly lower relapse rate was observed in the RUNX1-GLRX5-positive cases (P = 0.039), indicating that this chimera can be used as a biomarker for good prognosis in Stage IA patients. Detection of the RUNX1-GLRX5 chimeric transcript may therefore be useful for the determination of a postoperative treatment plan for Stage IA non-small-cell lung cancer patients. </div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">26685324</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>07</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1465-3621</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>46</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2016</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Japanese journal of clinical oncology</Title>
<ISOAbbreviation>Jpn J Clin Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.</ArticleTitle>
<Pagination>
<MedlinePgn>185-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/jjco/hyv187</ELocationID>
<Abstract>
<AbstractText>Stage IA non-small-cell lung cancer cases have been recognized as having a low risk of relapse; however, occasionally, relapse may occur. To predict clinical outcome in Stage IA non-small-cell lung cancer patients, we searched for chimeric transcripts that can be used as biomarkers and identified a novel chimeric transcript, RUNX1-GLRX5, comprising RUNX1, a transcription factor, and GLRX5. This chimera was detected in approximately half of the investigated Stage IA non-small-cell lung cancer patients (44/104 cases, 42.3%). Although there was no significant difference in the overall survival rate between RUNX1-GLRX5-positive and -negative cases (P = 0.088), a significantly lower relapse rate was observed in the RUNX1-GLRX5-positive cases (P = 0.039), indicating that this chimera can be used as a biomarker for good prognosis in Stage IA patients. Detection of the RUNX1-GLRX5 chimeric transcript may therefore be useful for the determination of a postoperative treatment plan for Stage IA non-small-cell lung cancer patients. </AbstractText>
<CopyrightInformation>© The Author 2015. Published by Oxford University Press.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ishikawa</LastName>
<ForeName>Rie</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Amano</LastName>
<ForeName>Yosuke</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kawakami</LastName>
<ForeName>Masanori</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sunohara</LastName>
<ForeName>Mitsuhiro</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Watanabe</LastName>
<ForeName>Kousuke</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kage</LastName>
<ForeName>Hidenori</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohishi</LastName>
<ForeName>Nobuya</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yatomi</LastName>
<ForeName>Yutaka</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakajima</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fukayama</LastName>
<ForeName>Masashi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagase</LastName>
<ForeName>Takahide</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takai</LastName>
<ForeName>Daiya</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo dtakai-ind@umin.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Jpn J Clin Oncol</MedlineTA>
<NlmUniqueID>0313225</NlmUniqueID>
<ISSNLinking>0368-2811</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050676">Core Binding Factor Alpha 2 Subunit</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C516011">GLRX5 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C493728">RUNX1 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002678" MajorTopicYN="N">Chimera</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050676" MajorTopicYN="N">Core Binding Factor Alpha 2 Subunit</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">GLRX5</Keyword>
<Keyword MajorTopicYN="N">RUNX1</Keyword>
<Keyword MajorTopicYN="N">biological markers</Keyword>
<Keyword MajorTopicYN="N">gene fusion</Keyword>
<Keyword MajorTopicYN="N">non-small-cell lung cancer</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>06</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>11</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>12</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>12</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26685324</ArticleId>
<ArticleId IdType="pii">hyv187</ArticleId>
<ArticleId IdType="doi">10.1093/jjco/hyv187</ArticleId>
<ArticleId IdType="pmc">PMC4731000</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Curr Opin Genet Dev. 2009 Feb;19(1):82-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19233641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2009 May 1;137(3):391-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19410533</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer Ther. 2009 Jun;8(6):1399-408</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19509239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Sci. 2013 Nov;104(11):1447-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23931849</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nucl Med. 2015 Jan;56(1):45-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25525185</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25559415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Genet. 2002 May;3(5):370-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11988762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2004 Jan 22;350(4):351-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14736927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2004 Apr 22;350(17):1713-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15102997</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2004 May 24;23(24):4198-208</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15156173</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Genet Metab. 1999 Jul;67(3):183-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10381326</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2005 Apr 15;18(2):245-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15837427</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2005 Jun 23;352(25):2589-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15972865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Cancer. 2007 Apr;7(4):233-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17361217</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Genet. 2009 Oct;10(10):691-703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19763152</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2011 May 31;108(22):9172-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21571633</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Res. 2012 Nov;22(11):2109-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22975805</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bioinformatics. 2012 Dec 15;28(24):3232-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23093608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Clin Exp Pathol. 2013;6(4):598-612</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23573306</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lung Cancer. 2007 Jun;56(3):341-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17350137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thorac Oncol. 2008 Jan;3(1):46-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18166840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Cancer. 2008 Jul;8(7):497-511</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18563191</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
<region>
<li>Région de Kantō</li>
</region>
<settlement>
<li>Tokyo</li>
</settlement>
</list>
<tree>
<country name="Japon">
<region name="Région de Kantō">
<name sortKey="Ishikawa, Rie" sort="Ishikawa, Rie" uniqKey="Ishikawa R" first="Rie" last="Ishikawa">Rie Ishikawa</name>
</region>
<name sortKey="Amano, Yosuke" sort="Amano, Yosuke" uniqKey="Amano Y" first="Yosuke" last="Amano">Yosuke Amano</name>
<name sortKey="Fukayama, Masashi" sort="Fukayama, Masashi" uniqKey="Fukayama M" first="Masashi" last="Fukayama">Masashi Fukayama</name>
<name sortKey="Kage, Hidenori" sort="Kage, Hidenori" uniqKey="Kage H" first="Hidenori" last="Kage">Hidenori Kage</name>
<name sortKey="Kawakami, Masanori" sort="Kawakami, Masanori" uniqKey="Kawakami M" first="Masanori" last="Kawakami">Masanori Kawakami</name>
<name sortKey="Nagase, Takahide" sort="Nagase, Takahide" uniqKey="Nagase T" first="Takahide" last="Nagase">Takahide Nagase</name>
<name sortKey="Nakajima, Jun" sort="Nakajima, Jun" uniqKey="Nakajima J" first="Jun" last="Nakajima">Jun Nakajima</name>
<name sortKey="Ohishi, Nobuya" sort="Ohishi, Nobuya" uniqKey="Ohishi N" first="Nobuya" last="Ohishi">Nobuya Ohishi</name>
<name sortKey="Sunohara, Mitsuhiro" sort="Sunohara, Mitsuhiro" uniqKey="Sunohara M" first="Mitsuhiro" last="Sunohara">Mitsuhiro Sunohara</name>
<name sortKey="Takai, Daiya" sort="Takai, Daiya" uniqKey="Takai D" first="Daiya" last="Takai">Daiya Takai</name>
<name sortKey="Watanabe, Kousuke" sort="Watanabe, Kousuke" uniqKey="Watanabe K" first="Kousuke" last="Watanabe">Kousuke Watanabe</name>
<name sortKey="Yatomi, Yutaka" sort="Yatomi, Yutaka" uniqKey="Yatomi Y" first="Yutaka" last="Yatomi">Yutaka Yatomi</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000405 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000405 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26685324
   |texte=   The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26685324" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GlutaredoxinV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020